In late 2007, the Alabama Supremes stunned many observers by overturning most of a $3.6 billion jury verdict in a fraud case against oil giant ExxonMobil. That decision robbed state coffers of badly needed funds at the outset of the Bush recession.
The high court was at it again recently, overturning a $274 million verdict in a fraud case against three pharmaceutical companies. The Supreme Court found that AstraZeneca, Novartis, and GlaxoSmithKline did not defraud the state in pricing Medicaid prescription drugs.
This issue goes well beyond Alabama. Similar lawsuits against pharmaceutical companies are pending in other states, including Mississippi, South Carolina, Utah, Hawaii, and Alaska.
That is like saying: "I tried to steal $500 out of your wallet, and I had my hand on the cash and was pulling it out, but you caught me--so I didn't do anything wrong."
If you think there is something wrong with that reasoning, join the crowd. It's almost exactly the same reasoning the Alabama Supreme Court used to justify the ExxonMobil ruling and its predecessor, Hunt Petroleum Corp. v. State (2004). In fact, the Supremes proudly cite Hunt Petroleum in their decision on the pharmaceutical case.
Here is the status of current fraud law in Alabama--at least as it relates to Big Oil and Big Pharma: The victim of a fraud cannot prevail unless he falls for the fraud totally and completely, from start to finish. Of course, if the victim falls totally for the fraud, he never knows he's been defrauded--and cannot possibly bring a case.
Under that interpretation of the "reliance" element, big business cannot commit fraud in Alabama. It is essentially open season on Alabama citizens.
We should point out a few oddities about the Big Pharma case. Justice Tom Parker, who wrote the bogus ExxonMobil decision, was the only justice to dissent on Big Pharma. And Chief Justice Sue Bell Cobb, the court's only Democrat and the only dissenting vote in the ExxonMobil case, concurred with the Big Pharma result--although she said the court used the wrong legal grounds to get the correct result.
Cobb either must be tired of fighting the business interests all by herself--or maybe they have bought her off, too, by now.
In his eight-page ruling, Price said the evidence during the trial showed that AstraZeneca's actions in overcharging Alabama's Medicaid program were "reprehensible.''
"The state introduced evidence to establish that the defendants fraudulently diverted Medicaid funds intended to benefit the state's poor, elderly and infirm citizens,'' Price wrote. "The state established that defendants' wrongful conduct deprived the state of limited funds available for the state's Medicaid recipients.''
The trial judge found Big Pharma's actions "reprehensible." But the Alabama Supreme Court says it was A-OK. That's what we get when we blindly vote for Republicans on our statewide courts, folks.
Price was not the only one blasting the behavior of Big Pharma in Alabama. Jere Beasley, one of the lawyers for the state, issued a scathing public statement about the drug companies--and the Alabama Supreme Court. Here is a portion of that statement:
The opinion of the Alabama Supreme Court is most difficult to understand when you consider that: